Académique Documents
Professionnel Documents
Culture Documents
FY13 Committee Approved Funding Senate: $670 million House: $650 million
Every year, 3.3 billion people are at risk of contracting malaria, leading to approximately 216 million malaria cases and an estimated 655,000 deaths. Thanks in part to President George W. Bushs leadership and the creation of the Presidential Malaria Initiative in 2005, which currently operates in 19 focus countries, international funding to combat malaria has continued to rise. However, funding still falls short of the $5 billion per year needed from 2010 to 2015 to reach malaria control targets.1 Additionally, robust funding for malaria research and development is necessary to sustain the remarkable gains made against the disease in the last decade. Significance of Funding Levels The extra $20 million dollars approved by the Senate Appropriations Committee for FY13 could provide: Bed nets for over 5 million people; Artemisnin-based Combination Therapy (ACT) treatment for more than 14 million people; or Rapid diagnostic testing (RDT) for 33 million people. Cost of Care $4.00 = Long-lasting insecticidal bed net that lasts three years $1.40 = ACT course for an adult $0.60 = Rapid diagnostic testing for children and adults2
Importance of Funding
The World Health Organization (WHO) estimates that half of the worlds population is at risk of malaria infection. Malaria is prevalent in 106 countries, referred to as malaria-endemic countries. Malaria imposes significant costs to both individuals and governments. Direct costs such as illness, treatment, or premature death have been estimated to be at least $12 billion per year. Indirect costs, like loss of economic growth, are many times more than that.3